ZANTE: Zometa and Taxotere in Hormone Refractory Prostate Cancer (ZANTE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00415779
Recruitment Status : Completed
First Posted : December 25, 2006
Last Update Posted : February 24, 2010
Information provided by:
National Cancer Institute, Naples

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2008
  Actual Study Completion Date : July 2009